New revisions of the Preliminary Assessment Review templates, forms and annexes
- Home
- regulatory updates
- New revisions of the Preliminary Assessment Review templates, forms and annexes
New revisions of the Preliminary Assessment Review templates, forms and annexes
Regulatory Affairs Medical Devices In Vitro Diagnostics
Monday, 27 January 2025
Kirsten Van Garsse, Authorized Representative Director & Regulatory Affairs Manager IVD
Share
\
\
X (Twitter) 
\
\
LinkedIn 
\
\
WhatsApp 
\
\
Copy link 
\
\
Mail
On January 10th, 2025, the Medical Device Coordination Group (MDCG) released new revisions of the Preliminary Assessment Review templates and the forms to apply for designation as Notified Body under Regulation (EU) 2017/745 (MDR) or Regulation (EU) 2017/746 (IVDR),as well as the annexes of these documents.
Play
New revisions of the Preliminary Assessment Review templates, forms and annexes | QbD Group
AI-generated audio
1:54
The documents are available in the Notified Body section of the MDCG Guidance webpage. The application forms are to be used by conformity assessment bodies that seek designation (or extension of designation) as notified body under MDR or IVDR. The preliminary assessment review (PAR) templates will be used by the designating authorities to document their review of the conformity assessment body’s application.
MDCG 2024-7 Rev. 1: Preliminary assessment review template – MDR (Regulation (EU) 2017/745).
MDCG 2021-15/MDCG 2024-7: Annex to Application Form & PAR Template MDR (List of documents).
MDCG 2024-8 Rev. 1: Preliminary assessment review template – IVDR (Regulation (EU) 2017/746).
MDCG 2021-16/MDCG 2024-8 Annex: Annex to Application Form & PAR Template IVDR (List of documents).
What is updated:
- MDCG 2021-15 and MDCG 2021-16 were updated to align the document structure with respectively MDR Annex VII and IVDR Annex VII, and related Preliminary assessment review (PAR) form templates (respectively MDCG 2024-7 and MDCG 2024-8)
- MDCG 2024-7 and MDCG 2024-8 were updated by removing in each document a section due to redundancy in its use by notified bodies.
- The Annexes to each Application Form and PAR template contain a checklist of documents to be submitted with the application
What does it mean to you?
MDCG 2021-15/16, MDCG 2024-7/8 and the annexes to these documents are of relevance for the designation of notified bodies under MDR and IVDR. As such, they do not have an immediate impact on manufacturers and other economic operators under IVDR or MDR.
They are of interest for those who wish to better understand the designation process of notified bodies under the medical device Regulations.
Discover more expert content
Previous
Regulatory Affairs
23 Apr 2025
New Revision to MDCG 2020-16 Guidenance Document Released
This fourth revision of MDCG 2020-16 focuses on devices to detect infectious agents, and in...
Regulatory Affairs
10 Jan 2025
New MDCG 2020-16 Revision 3 Guidance Documents Released
MDCG 2020-16 Revision 3: Guidance on classification Rules for in vitro Diagnostic Medical Devices...
Regulatory Affairs
27 Jan 2025
Second revision to MDCG 2023-3 Guidance document released
MDCG 2023-3 Rev. 2: Questions and Answers on vigilance terms and concepts as outlined in the...
Regulatory Affairs
5 Mar 2025
Fifth revision to MDCG 2019-6 Guidance document released
MDCG 2019-6 Rev. 5: Questions and Answers on requirements relating to notified bodies.
Regulatory Affairs
23 Dec 2024
Revision of MDCG 2019-13 released
MDCG 2019-13 Rev.1: Guidance on sampling of MDR Class IIa / Class IIb and IVDR Class B / Class C...
Regulatory Affairs
23 Apr 2025
New Revision to MDCG 2020-16 Guidenance Document Released
This fourth revision of MDCG 2020-16 focuses on devices to detect infectious agents, and in...
Regulatory Affairs
10 Jan 2025
New MDCG 2020-16 Revision 3 Guidance Documents Released
MDCG 2020-16 Revision 3: Guidance on classification Rules for in vitro Diagnostic Medical Devices...
Regulatory Affairs
27 Jan 2025
Second revision to MDCG 2023-3 Guidance document released
MDCG 2023-3 Rev. 2: Questions and Answers on vigilance terms and concepts as outlined in the...
Regulatory Affairs
5 Mar 2025
Fifth revision to MDCG 2019-6 Guidance document released
MDCG 2019-6 Rev. 5: Questions and Answers on requirements relating to notified bodies.
Regulatory Affairs
23 Dec 2024
Revision of MDCG 2019-13 released
MDCG 2019-13 Rev.1: Guidance on sampling of MDR Class IIa / Class IIb and IVDR Class B / Class C...
Regulatory Affairs
23 Apr 2025
New Revision to MDCG 2020-16 Guidenance Document Released
This fourth revision of MDCG 2020-16 focuses on devices to detect infectious agents, and in...
Regulatory Affairs
10 Jan 2025
New MDCG 2020-16 Revision 3 Guidance Documents Released
MDCG 2020-16 Revision 3: Guidance on classification Rules for in vitro Diagnostic Medical Devices...
Next
- 1
- 2
- 3
Stay ahead in life sciences
Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.
Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.
Twitter Widget Iframe